Evidence map›Paper›PMID 39314239›Full record

ArticleiScience2024

Erik P Lillehoj, Yafan Yu, Avelino C Verceles, Akihiro Imamura, Hideharu Ishida, Kurt H Piepenbrink, Simeon E Goldblum

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Measuring C. difficile Adhesion to Mucosal Surfaces.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Erik P LillehojDepartment of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, USA.
Yafan YuDepartment of Biochemistry, University of Nebraska, Lincoln, NE, USA.
Avelino C VercelesDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Akihiro ImamuraInstitute for Glyco-core Research (iGCORE), Gifu University, Gifu, Japan.
Hideharu IshidaInstitute for Glyco-core Research (iGCORE), Gifu University, Gifu, Japan.
Kurt H PiepenbrinkDepartment of Biochemistry, University of Nebraska, Lincoln, NE, USA.
Simeon E GoldblumDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.

Funding

MUC1 Biotherapeutics for Pseudomonas aeruginosa InfectionsR21AI144497 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LILLEHOJ, ERIK P · 2019 to 2020
$425k
NIAID NIH HHS R21 AI144497
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell biologyMolecular microbiology

Identifiers

PMID39314239
PMCPMC11418149

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.